Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in Guangzhou, China, 1996-2001

Sexually Transmitted Infections

Volumn 79, Issue 5, 2003, Pages 399-402

  Zheng, H P ^a   Cao, W L ^a   Wu, X Z ^a   Yang, L G ^a  

^a Guangzhou Center for STD Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; CIPROFLOXACIN; PENICILLIN G; PENICILLINASE; SPECTINOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHINA; CONTROLLED STUDY; DILUTION; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CEFTRIAXONE; CIPROFLOXACIN; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; GONORRHEA; HUMANS; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; PENICILLIN G; SPECTINOMYCIN;

EID: 0142179900     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.79.5.399     Document Type: Article

References (14)

1. Zhang J. The past, today and future of STDs in China. Chinese J Epidemiol 1998;19:118-21.
2. Zheng D, Chen Y, Diao J, et al. Analysis on STD epidemiological characteristics of Guangdong province. South China J Dermato-venereol 2002;2:51-4.
3. Ye S. Survey on antibiotic sensitivity of Neisseria gonorrhoeae strains isolated in China. Sex Transm Dis 1994;21:237-9.
4. Cao W, Fei S, Zou G, et al. Analysis of antibiotic susceptibility of Neisseria gonorrhoeae in Guangzhou. J Clin Dermatol 1999;28:223-4.
5. WHO Western Pacific Region Gonococcal Surveillance Programme. Surveillance of antibiotic susceptibility of Neisseria gonorrhoeae in the WHO Western Pacific Region 1992-4. Genitourin Med 1997;73:355-61.
6. Van Dyck E, Piot P, Meheus A. Bench-level laboratory manual for sexually transmitted diseases, VDT/89.443. Geneva: World Health Organization, 1989.
7. The WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme. Commun Dis Intell 2001;25:274-7.
8. Centers for Disease Control. Sexually transmitted diseases treatment guidelines. MMWR 1989;38(s-8):9-24.
9. Kam K, Wong P, Cheung M, et al. Quinolone-resistant Neisseria gonorrhoeae in Hong Kong. Sex Transm Dis 1996;23:102-8.
10. Deguchi T, Yasuda M, Asano M, et al. DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae. Antimcrob Agents Chemother 1995;39:561-3.
11. Tapsall JW, Philips EA, Shultz TR, et al. Quinolone-resistant Neisseria gonorrhoeae isolated in Sydney, Australia, 1991 to 1995. Sex Transm Dis 1996;23:425-7.
12. World Health Organization. Guidelines for the management of sexually transmitted infections, WHO/HIV-AIDS/(2001).01; WHO/RPR/01.10:pp 1-5. Geneva: WHO, 2001:1-5.
13. Rahman M, Alam A, Nessa K, et al. Treatment failure with the use of ciprofloxacin for gonorrhea correlates with the prevalence of fluoroquinolone-resistant Neisseria gonorrhoeae strains in Bangladesh. Clin Infect Dis 2001;32:844-9.
14. Ye S, Su X. Sensitivity test of Neisseria gonorrhoeae strains to ceftriaxone. Chinese J Dermato-venereol 1998;12:268-9.